These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12926197)

  • 1. [Opatanol].
    Johansen S
    Ugeskr Laeger; 2003 Jul; 165(30):2957. PubMed ID: 12926197
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis.
    Kamis U; Ozturk BT; Ozkagnici A; Gunduz K
    Acta Ophthalmol Scand; 2006 Feb; 84(1):148-9. PubMed ID: 16445458
    [No Abstract]   [Full Text] [Related]  

  • 3. Olopatadine for allergic conjunctivitis.
    Med Lett Drugs Ther; 1997 Nov; 39(1014):108-9. PubMed ID: 9398823
    [No Abstract]   [Full Text] [Related]  

  • 4. [Second generation topical antihistaminics].
    Pietrzkowicz M; Grzelewska-Rzymowska I
    Pol Merkur Lekarski; 1999 May; 6(35):277-80. PubMed ID: 10437402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis].
    Endre L; Hidasi V
    Orv Hetil; 2006 Sep; 147(36):1741-3. PubMed ID: 17087018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Olopatadine].
    Taéron C
    Rev Infirm; 2004 Apr; (100):43-4. PubMed ID: 15222186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Misleading advertisement on Opatanol].
    Timmermans AE
    Ned Tijdschr Geneeskd; 2006 Jul; 150(26):1472. PubMed ID: 16875272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.
    Vogelson CT; Abelson MB; Pasquine T; Stephens DM; Gamache DA; Gross RD; Robertson SM; Yanni JM
    Allergy Asthma Proc; 2004; 25(1):69-75. PubMed ID: 15055565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allergic conjunctival disorders].
    Ebihara N
    Nihon Rinsho; 2005 May; 63 Suppl 5():107-13. PubMed ID: 15954334
    [No Abstract]   [Full Text] [Related]  

  • 11. Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.
    Trattler WB; Luchs J; Majmudar P
    Int Ophthalmol Clin; 2006; 46(4):87-99. PubMed ID: 17060795
    [No Abstract]   [Full Text] [Related]  

  • 12. Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.
    Rosenwasser LJ; O'Brien T; Weyne J
    Curr Med Res Opin; 2005 Sep; 21(9):1377-87. PubMed ID: 16197656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergodil eye drops in the treatment of allergic conjunctivitis].
    Haicl P; Cerná H
    Cesk Slov Oftalmol; 2002 Jul; 58(4):254-8. PubMed ID: 12181881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical update: new medications for ocular allergy.
    Trayner EM
    N J Med; 1994 Sep; 91(9):607. PubMed ID: 7970285
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonsteroidal eye drops for ocular allergy.
    Schwab IR
    West J Med; 1994 Dec; 161(6):594-5. PubMed ID: 7856163
    [No Abstract]   [Full Text] [Related]  

  • 16. [Levocabastine--a new antihistaminic for local treatment].
    Larsen BB; Pedersen B; Dahl R
    Ugeskr Laeger; 1993 Jun; 155(26):2070-3. PubMed ID: 8101023
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
    Leonardi A; Zafirakis P
    Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic levocabastine for allergic conjunctivitis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):35-6. PubMed ID: 7908401
    [No Abstract]   [Full Text] [Related]  

  • 19. Duration of action of topical antiallergy drugs in a Guinea pig model of histamine-induced conjunctival vascular permeability.
    Beauregard C; Stephens D; Roberts L; Gamache D; Yanni J
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):315-20. PubMed ID: 17803429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular allergy: diagnosis and treatment.
    Butrus S; Portela R
    Ophthalmol Clin North Am; 2005 Dec; 18(4):485-92, v. PubMed ID: 16314214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.